论文部分内容阅读
目的：观察降粘胶囊治疗高粘滞血症的疗效。方法：高粘滞血症患者３９４例随机分为治疗组１９８例和对照组１９６例。将口服降粘胶囊治疗组和口服茶色素胶囊对照组作比较。结果：治疗组治疗后血液流变学指标较治疗前明显改善（Ｐ＜０．０５～０．０１）。治疗组总有效率为９４．９％，对照组为８５．２％，治疗组疗效明显优于对照组（Ｐ＜０．０５）；治疗组治疗后总胆固醇、甘油三酯和血糖较治疗前明显下降（Ｐ均＜０．０１），高密度脂蛋白则明显上升（Ｐ＜０．０１）。结论：降粘胶囊具有降低血脂、血糖、血液粘稠度及改善微循环、防止动脉硬化等作用，是预防和治疗高粘滞血症的有效药物。
Objective: To observe the effect of Jiangmian Capsule in treating hyperviscosity. Methods: 394 patients with hyperviscosity were randomly divided into treatment group 198 cases and control group 196 cases. Oral hypodermic capsule treatment group and oral tea pigment capsule for comparison. Results: The hemorrheological indexes in the treatment group were significantly improved after treatment (P <0.05 ~ 0.01). The total effective rate was 94.9% in the treatment group and 85.2% in the control group, and the therapeutic effect in the treatment group was significantly better than that in the control group (P <0.05). The total cholesterol, triglyceride and blood glucose in the treatment group were significantly lower than those before treatment (P <0.01), and high density lipoprotein increased significantly (P <0.01). Conclusion: Jiangmian capsule can reduce blood fat, blood sugar, blood viscosity and microcirculation, prevent atherosclerosis and other effects, is an effective drug in the prevention and treatment of hyperviscosity.